Profile
Jeff Hammel worked as a Controller at Eli Lilly & Co. and as a Chief Financial Officer at Orthofix Medical, Inc. He also served as the Chief Financial Officer at Kuur Therapeutics Ltd.
from 2013 to 2018.
Former positions of Jeff Hammel
| Companies | Position | End |
|---|---|---|
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Director of Finance/CFO | 15/02/2018 |
| ELI LILLY AND COMPANY | Comptroller/Controller/Auditor | - |
| ORTHOFIX MEDICAL INC. | Director of Finance/CFO | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ORTHOFIX MEDICAL INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| Private companies | 1 |
|---|---|
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Jeff Hammel
